scispace - formally typeset
G

George M. Weinstock

Researcher at Washington University in St. Louis

Publications -  488
Citations -  158810

George M. Weinstock is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Genome & Gene. The author has an hindex of 122, co-authored 482 publications receiving 144274 citations. Previous affiliations of George M. Weinstock include University of Texas at Austin & Memorial Sloan Kettering Cancer Center.

Papers
More filters
Journal ArticleDOI

New statistical method identifies cytokines that distinguish stool microbiomes

TL;DR: This paper proposes and applies a new regression model combining the Dirichlet-multinomial distribution with recursive partitioning providing a fully non-parametric regression model, called DM-RPart, which is applied to cytokine data and microbiome taxa count data and is applicable to any microbiomeTaxa count/metadata, is automatically fit, and intuitively interpretable.
Journal ArticleDOI

The Escherichia fergusonii iucABCD iutA genes are located within a larger chromosomal region similar to pathogenicity Islands.

TL;DR: Three strains ofEscherichia fergusonii (EF873, EF1496, EF939) of 50 strains tested produced the hydroxamate siderophore aerobactin, suggesting that E. f Fergusonii iucABCD iutA genes are a portion of a larger segment of DNA similar to pathogenicity islands of other bacteria.
Journal ArticleDOI

Shotgun sequencing, clone pooling, and comparative strategies for mapping and sequencing

TL;DR: This article focuses on the following two key innovations in mapping and sequencing: first, shotgun sequencing of clone pools to combine the benefits of whole-genome shotgun and clone-by-clone strategies, and the leveraging of newly available assembled genomic sequences to improve the effectiveness of new sequencing projects through comparative mapping and comparative sequence assembly.
Journal ArticleDOI

A Glimpse of Microbial Power in Preventive Medicine.

TL;DR: The authors observed a reduction in risk of islet autoimmunity in the children who had received dietary supplements of probiotics at or before age 27 days compared with those who first received probiotics after 27 days of life, suggesting early exposure to supplemental probiotics may decrease the risk of IA among children at elevated risk of T1DM.